This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
RF Anton , G Oroszi , S O'Malley , D Couper , (2008). An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Archives of General Psychiatry 65, 135–144.
C Bond , KS LaForge , M Tian , D Melia , (1998). Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proceedings of the National Academy of Sciences USA 95, 9608–9613.
CJ Endres , B Bencherif , J Hilton , I Madar , (2003). Quantification of brain mu-opioid receptors with [11C]carfentanil: reference-tissue methods. Nuclear Medicine and Biology 30, 177–186.
P Huang , C Chen , SD Mague , JA Blendy , (2012). A common single nucleotide polymorphism A118G of the mu opioid receptor alters its N-glycosylation and protein stability. Biochemical Journal 441, 379–386.
W Huang , DE Moody , RL Foltz , SL Walsh (1997). Determination of naltrexone and 6-beta-naltrexol in plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry. Journal of Analytical Toxicology 21, 252–257.
PE Kinahan , JG Rogers (1989). Analytic 3D image reconstruction using all detected events. IEEE Transactions on Nuclear Science 36, 964–968.
HR Kranzler , HJ Edenberg (2010). Pharmacogenetics of alcohol and alcohol dependence treatment. Current Pharmaceutical Design 16, 2141–2148.
J Lotsch , G Geisslinger (2011). Pharmacogenetics of new analgesics. British Journal of Pharmacology 163, 447–460.
ME McCaul , GS Wand , C Rohde , SM Lee (2000). Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers. Alcohol Clinical and Experimental Research 24, 1385–1391.
DW Oslin , WH Berrettini , CP O'Brien (2006). Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone. Addiction Biology 11, 397–403.
R Ray , K Ruparel , A Newberg , EP Wileyto , (2011 b). Human mu opioid receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proceedings of the National Academy of Sciences USA 108, 9268–9273.
E Setiawan , RO Pihl , SM Cox , C Gianoulakis , (2011). The effect of naltrexone on alcohol's stimulant properties and self-administration behavior in social drinkers: influence of gender and genotype. Alcoholism Clinical Experimental Research 35, 1134–1141.
MW Smith , JA Lautenberger , HD Shin , JP Chretien , (2001). Markers for mapping by admixture linkage disequilibrium in African American and Hispanic populations. American Journal of Human Genetics 69, 1080–1094.
LC Sobell , MB Sobell (1992). Timeline followback: a technique for assessing self-reported alcohol consumption. In: RZ Litten , J Allen , (Eds.), Measuring Alcohol Consumption: Psychosocial and Biological Methods. Totowa, NJ: Humana Press; pp. 41–72.
JW Tidey , PM Monti , DJ Rohsenow , CJ Gwaltney , (2008). Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. Alcoholism Clinical and Experimental Research 32, 58–66.
M Uhart , GS Wand (2009). Stress, alcohol and drug interaction: an update of human research. Addiction Biology 14, 43–64.
E van den Wildenberg , RW Wiers , J Dessers , RG Janssen , (2007). A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers. Alcoholism Clinical and Experimental Research 31, 1–10.
EM Weerts , YK Kim , GS Wand , RF Dannals , (2008). Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects. Neuropsychopharmacology 33, 653–665.
EM Weerts , GS Wand , H Kuwabara , CA Munro , (2011). Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects. Alcoholism Clinical and Experimental Research 35, 2162–2163.
BZ Yang , H Zhao , HR Kranzler , J Gelernter (2005). Practical population group assignment with selected informative markers: characteristics and properties of Bayesian clustering via STRUCTURE. Genetics and Epidemiology 28, 302–312.
Y Zhang , D Wang , AD Johnson , AC Papp , (2005). Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. Journal of Biological Chemistry 280, 32618–32624.